From the JCVI
On children and young people aged 12-15 who do not have underlying health conditions, the JCVI have advised that the benefits from vaccination are marginally greater than the potential known harms but that there is considerable uncertainty regarding the magnitude of the potential harms. From an individual health benefit perspective, they feel the margin of benefit, is considered too small to support advice on a universal programme of vaccination of otherwise healthy 12-15-year-old children at this time. They do however acknowledge that there may be wider issues to consider which are outside the remit of the JCVI to evaluate, such as wider societal impacts, including educational benefits, where the CMO would be better placed to advise, with representation from JCVI.